Abeona TherapeuticsABEO
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 48 institutions reported holding Abeona Therapeutics Inc. (ABEO) in their 13F filings, down 8 from Q1 2024. 12 opened new positions and 19 sold out. The largest holders were Montanova Capital, LLC ($15.6M), Nantahala Capital Management, LLC ($14.7M) and Adage Capital Partners Gp, L.L.C. ($13.8M). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Abeona Therapeutics Inc.
- CUSIP
- 00289Y206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 12 | $43.3M |
| Exits | 19 | $4.8M |
All 13F filers, Q1 2024 → Q2 2024: 16,582,158 shares bought and 888,912 shares sold, net +15,693,246 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 48 holders
| Montanova Capital, LLC | 0.64% | New | 3,685,503 | $15.6M |
| Nantahala Capital Management, LLC | 1.48% | Add +50.2% | 3,470,037 | $14.7M |
| Adage Capital Partners Gp, L.L.C. | 0.03% | No change | 3,249,994 | $13.8M |
| Millennium Management | 0.01% | Add +34.7% | 2,676,651 | $11.3M |
| Vanguard Group Inc. | 0.00% | Add +77.3% | 1,953,501 | $8.3M |
| Vivo Capital, LLC | 0.72% | New | 1,842,751 | $7.8M |
| Rosalind Advisors, Inc. | 5.87% | New | 1,750,000 | $7.4M |
| Western Standard LLC | 6.97% | Add +16.6% | 1,587,099 | $6.7M |
| Laurion Capital Management LP | 0.21% | Add +132.9% | 1,506,780 | $6.4M |
| Propel Bio Management, LLC | 3.43% | New | 1,248,044 | $5.3M |
| Walleye Capital LLC | 0.05% | Add +272.2% | 990,384 | $4.2M |
| Ikarian Capital, LLC | 1.02% | Reduce -13.5% | 768,593 | $3.3M |
| 683 Capital Management, LLC | 0.30% | New | 600,000 | $2.5M |
| Morgan Stanley | 0.00% | Add +1820.4% | 595,998 | $2.5M |
| Renaissance Technologies | 0.00% | Add +581.6% | 503,293 | $2.1M |
| Citigroup Inc. | 0.00% | Add +1.3% | 490,336 | $2.1M |
| BlackRock Inc. | 0.00% | Add +102.4% | 446,439 | $1.9M |
| Simplify Asset Management Inc. | 0.15% | New | 408,584 | $1.7M |
| Geode Capital Management, LLC | 0.00% | Add +58.1% | 382,267 | $1.6M |
| Newtyn Management, LLC | 0.31% | New | 380,000 | $1.6M |
| Boothbay Fund Management, LLC | 0.03% | Reduce -13.5% | 233,832 | $991K |
| Bank of America Corp. | 0.00% | Add +903.9% | 230,987 | $979K |
| Northern Trust Corp. | 0.00% | Add +34.9% | 173,550 | $736K |
| State Street Corp. | 0.00% | Add +88.3% | 161,895 | $686K |
| Aberdeen Group plc | 0.00% | New | 126,348 | $536K |
| Bank of New York Mellon Corp | 0.00% | Add +2.0% | 121,453 | $515K |
| ADAR1 Capital Management, LLC | 0.10% | New | 113,125 | $480K |
| Barclays PLC | 0.00% | Add +35.5% | 76,394 | $324K |
| Gsa Capital Partners LLP | 0.02% | Add +153.5% | 62,261 | $264K |
| LPL Financial LLC | 0.00% | Add +66.9% | 50,985 | $216K |
| Susquehanna International Group, LLP | 0.00% | Add +73.2% | 47,563 | $202K |
| JPMorgan Chase & Co. | 0.00% | Add +77.9% | 38,532 | $163K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +135.3% | 37,977 | $161K |
| Virtu Financial LLC | 0.01% | New | 34,615 | $147K |
| Corient Private Wealth LP | 0.00% | Add +61.2% | 22,404 | $95K |
| Oxford Asset Management LLP | 0.08% | New | 19,059 | $81K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -73.9% | 19,016 | $81K |
| Osaic Holdings, Inc. | 0.00% | Add +969.0% | 11,812 | $50K |
| Creative Planning | 0.00% | Reduce -33.1% | 10,043 | $43K |
| Group One Trading LLC | 0.00% | Add +257.6% | 6,283 | $27K |
| Citadel Advisors | 0.00% | Add +105650.0% | 4,230 | $18K |
| UBS Group AG | 0.00% | Reduce -71.3% | 3,000 | $13K |
| Parallel Advisors, LLC | 0.00% | No change | 400 | $2K |
| Royal Bank of Canada | 0.00% | Reduce -73.3% | 214 | $1K |
| Activest Wealth Management | 0.00% | New | 120 | $509 |
| Wells Fargo & Company | 0.00% | Reduce -75.4% | 60 | $254 |
| Rhumbline Advisers | 0.00% | Reduce -6.9% | 54 | $228 |
| Lazard Asset Management LLC | 0.00% | Reduce -85.5% | 163 | $0 |
"% of holder's portfolio" is ABEO's weight in each manager's 13F, not the share of Abeona Therapeutics Inc. the manager owns.